Skip to Main Content

News Center

Maureen Kane

Faculty Members’ Research Impacts FDA Guidance

November 30, 2021

Adjustments on detection method, type of trial should make it easier to gain approval of generic injectable iron drugs.

Probiotic-Containing Yogurt Protects Against Microbiome Changes That Lead to Antibiotic-Induced Diarrhea, Study Finds

September 15, 2021

Multi-Disciplinary Team of Researchers – Including UMSOP’s Mass Spectrometry Experts – Identify Mechanism of Protection Conferred by Probiotic Supplement

Local Technology, Global Impact

October 1, 2018

Dr. Maureen Kane’s leadership of the Mass Spectrometry Center make her a UMB Champion of Excellence.

SOP Faculty Receive $1.5 Million from the FDA to Study Iron Medications

February 24, 2015

Interdisciplinary group will research the effectiveness of brand versus generic iron medications used to treat anemia in kidney disease patients

SOP’s Kane to Test New Biomarkers of Fetal Alcohol Spectrum Disorders

September 10, 2014

Collaboration with University of New Mexico College of Pharmacy will employ expertise of the School’s Mass Spectrometry Center.

CERSI Conference Spotlights Need for Mass Spectrometry in Drug Development

April 16, 2014

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

SOP Mass Spectrometry Facility Hosts First-Ever Open House

October 29, 2013

Event highlights cutting-edge mass spectrometry instrumentation and services available to faculty, staff, and students at the University of Maryland, Baltimore.